MedPath

High-definition Transcranial Direct Current Stimulation for Facilitating Hand Function Recovery After Stroke

Not Applicable
Completed
Conditions
Stroke
Interventions
Device: HD-tDCS group
Device: Conventional tDCS group
Device: Sham HD-tDCS group
Registration Number
NCT03875677
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

Transcranial direct current stimulation (tDCS) had recently been shown having feasibility in modulating cortical excitability transiently during motor training in a noninvasive way. The findings support that tDCS and motor practice can positively promote post-stroke motor learning to improve upper-limb motor recovery after stroke. A randomized controlled trial will be conducted with three groups: HD-tDCS, conventional tDCS and sham HD-tDCS. A 10-session training will be provided to evaluate the effectiveness of transient modulation of cortical excitability through tDCS with clinical assessment scores.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  1. Hemiparesis subsequent to first-ever unilateral stroke for more than 6 months;
  2. MCP and PIP finger joints can be extended to 180° passively;
  3. Sufficient cognition to follow the experimental instructions
Exclusion Criteria
  1. Severe hand spasticity or hand deformity;
  2. History of alcohol or drug abuse or epilepsy;
  3. Bilateral brain infarcts;
  4. Severe cognitive deficits;
  5. Comprehensive aphasia;
  6. Contraindications to tDCS

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HD-tDCS groupHD-tDCS groupConstant current (1mA) will be applied for 20min and the anode will be placed over the defined target area
Conventional tDCS groupConventional tDCS groupConstant current (1mA) will be applied for 20min and the anode will be placed over the standard C3/C4 position
Sham HD-tDCS groupSham HD-tDCS groupThe stimulator will be shut down after 30s of stimulation. The patients will feel the initial itching sensation at the beginning in order to evaluate the placebo effect.
Primary Outcome Measures
NameTimeMethod
Action Research Arm Test (ARAT)3-month after the 10th session training

The ARAT has total 19 items, divided into 4 categories (grasp, grip, pinch, and gross arm movement). It ranges from 3 to 0 (best to worse).

Secondary Outcome Measures
NameTimeMethod
Fugl-Meyer Assessment (Upper Extremity)3-month after the 10th session training

The maximum score is 66, divided into 33 items in the form of a 3-point scale (0-2), 0 is cannot perform and 2 performs fully.

Magnetic Resonance ImagingBaseline

Functional magnetic resonance imaging

Wolf Motor Function Test (WMFT)3-month after the 10th session training

The WMFT measures upper limb ability through timed and functional tasks. It has 17 items, ranging from 0 to 5 (worse to best).

Trial Locations

Locations (1)

Department of Biomedical Engineering, The Chinese University of Hong Kong

🇭🇰

Shatin, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath